Arcturus Therapeutics
ARCT
$26.63
Share price
0.30%
Change (1 day)
1.95%
Change (1 year)
Arcturus Therapeutics (ARCT) - Net assets
Net assets on the balance sheet as of December 2023 : $0.27 B
According to Arcturus Therapeutics
's latest financial reports the company has $0.27 B in net assets.
A company’s net assets is the sum of its assets minus the sum of its liabilities.
Arcturus Therapeutics - Net assets on balance sheet (from 2012 to 2023)
Net assets by year
| Year | Net assets | Change |
|---|---|---|
| 2023-12-31 | $0.27 B | 3.03% |
| 2022-12-31 | $0.27 B | 18.45% |
| 2021-12-31 | $0.22 B | -42.45% |
| 2020-12-31 | $0.39 B | 1437.5% |
| 2019-12-31 | $25.79 M | 89.06% |
| 2018-12-31 | $13.64 M | -59.63% |
| 2017-12-31 | $33.79 M | 2042.93% |
| 2016-12-31 | $1.57 M | -97.73% |
| 2015-12-31 | $69.33 M | 247.65% |
| 2014-12-31 | $19.94 M | -59.04% |
| 2013-12-31 | $48.68 M | -8686.95% |
| 2012-12-31 | $-0.57 M | -157.56% |
| 2011-12-31 | $0.98 M |
Net assets for similar companies or competitors
| Company | Net assets | differencediff. | Country |
|---|---|---|---|
 Nymox Pharmaceutical NYMX | -$2.88 M | -101.03% | Bahamas |
 NRC Health
NRC | $48.95 M | -82.42% | 🇺🇸 USA |